<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="35664">Statins</z:chebi> have immunomodulatory effects </plain></SENT>
<SENT sid="1" pm="."><plain>Hence, they could be advantageous for different reasons </plain></SENT>
<SENT sid="2" pm="."><plain>First, <z:chebi fb="0" ids="35664">statins</z:chebi> can serve as adjunct therapy in <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Second, they may play a role in the prevention of <z:hpo ids='HP_0004943'>accelerated atherosclerosis</z:hpo> in the same population </plain></SENT>
<SENT sid="4" pm="."><plain>In this review, we discuss the mechanisms of immune regulation by <z:chebi fb="0" ids="35664">statins</z:chebi> and review the literature for their benefit in many <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In these studies, <z:chebi fb="0" ids="35664">statins</z:chebi> lead to an improvement in the disease activity scores in <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> patients; a reduction in prothrombotic factors in anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome patients; changes in vasculature, <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, and cardiac events in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> patients; changes in vasculature and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> in patients with <z:hpo ids='HP_0002633'>vasculitis</z:hpo>; disease activity scores in <z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">ankylosing spondylitis</z:e>; and finally vascular changes in patients with systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Hence, these studies suggest that <z:chebi fb="0" ids="35664">statins</z:chebi> could be used as adjuncts to standard therapy due to their anti-inflammatory, immunomodulatory, and anti-thrombogenic effects </plain></SENT>
<SENT sid="7" pm="."><plain>More evidence-based research is required to determine whether <z:chebi fb="0" ids="35664">statin</z:chebi> regimens will become the standard of care in patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
</text></document>